Merck License to Company. Merck hereby grants to Company a non-exclusive, worldwide, royalty-free, fully paid-up, transferable and sublicensable license to any patent Controlled by Merck that [*****] (the “Merck Background Patents”) solely for [*****]; provided, however, that in no event shall Company have the right to use Merck Background Patents to commercialize the Merck Compound or any PD-1 Antagonist.
Appears in 2 contracts
Samples: Clinical Trial Collaboration and Supply Agreement (ONCOSEC MEDICAL Inc), Clinical Trial Collaboration and Supply Agreement (ONCOSEC MEDICAL Inc)
Merck License to Company. Merck hereby grants to Company a non-exclusivenonexclusive, worldwide, royalty-free, fully paid-up, transferable and sublicensable license to any patent Controlled by Merck that [*****] * (the “Merck Background Patents”) solely for [*****]; provided, however, that in no event shall Company have the right to use exploit Merck Background Patents to commercialize the Merck Compound or any PD-1 Antagonist. *Confidential material redacted and filed separately with the Commission.
Appears in 1 contract
Samples: Clinical Trial Collaboration and Supply Agreement (ONCOSEC MEDICAL Inc)
Merck License to Company. Merck hereby grants to Company a non-non- exclusive, worldwide, royalty-free, fully paid-up, transferable and sublicensable license to any patent Controlled by Merck that [*****] * (the “Merck Background Patents”) solely for [*****]; provided, however, that in no event shall Company have the right to use exploit Merck Background Patents to commercialize sell the Merck Compound or any PD-1 Antagonist, either alone or as part of a combination (including the Combination).
Appears in 1 contract
